Versamune® HPV | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

35,699 results for “Versamune® HPV”

Trials

View all 30724 →

Adding Male Single Dose HPV Vaccination to Female HPV Vaccination in Tanzania

10,400 participants · First posted Jul 7, 2021

Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System

12,896 participants · First posted Sep 9, 2009

Prime-boost Vaccine Study in Women With Low-grade Cervical HPV Lesions

108 participants · First posted Oct 29, 2020

Drugs

View all 1770 →

PDS-0103

X-Synergy®

NanoLithium® NP03

Organizations

View all 12 →

GENOMIC HEALTH, INC.

United States

Theralase Technologies Inc

Canada

Merck & Co Inc

United States

News

View all 3193 →

Versamune® HPV Shows Promising ctDNA Clearance and Survival Rates in Advanced Cervical Cancer Trial

PDS Biotech's Versamune® HPV Plus Pembrolizumab Shows Promising Results in Head and Neck Cancer

PDS Biotech's Versamune® HPV Shows Promising Results in Head and Neck Cancer Trial

Page 1 of 3570